Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines

SJ Wall, RP Yasuda, M Li and BB Wolfe

Department of Pharmacology, Georgetown University School of Medicine, Washington, D. C. 20007.

A synthetic oligopeptide (QCDKRKRRKQQYQQRQSV) corresponding to a carboxyl-terminal sequence of the rat m3 receptor (amino acids 561-578) was coupled to carrier proteins and used to generate a polyclonal antiserum. This serum selectively immunoprecipitates at least 90% of the m3 receptors expressed by A9 cells transfected with the cDNA encoding the m3 muscarinic receptor but does not precipitate receptors from cells transfected with cDNA encoding m1, m2, m4, or m5 receptors. Using this m3 antiserum, the density of m3 receptors in various regions of rat brain was quantified. Areas expressing the highest density of m3 receptors are the cortex, hippocampus, striatum, and olfactory tubercle, with 232 fmol/mg, 197 fmol/mg, 140 fmol/mg, and 130 fmol/mg, respectively. Hindbrain regions (i.e., cerebellum, thalamus/hypothalamus, and pons/medulla) expressed fewer m3 receptors, both as a percentage of total muscarinic receptors (5-6%) and in terms of absolute receptor density (12-70 fmol/mg). A panel of subtype- selective antisera (m1, m2, and m3) was used to determine receptor distribution in several peripheral tissues of the rat (lung, ileum, and bladder). The m2 receptor subtype constitutes the majority of total receptors in the bladder (86%), lung (91%), and ileum (69%). The m3 receptor was found at lower densities in these tissues (5-11%), whereas the m1 receptor is present in highest amounts in the ileum (17%). Human clonal cell lines, in which regulation of muscarinic receptors has been commonly studied, were also examined. The SK-N-SH neuroblastoma line, which has been reported to express M3 receptors, on the basis of pharmacology and molecular size, was found to express a mixture of subtypes (m1 = 31%, m2 = 21%, m3 = 43%). Interestingly, SH-SY-5Y and SH- IN cells, both derived from SK-N-SH cells, exhibit predominantly m3 receptors (74% for SH-SY-5Y; 58% for SH-IN), with lower levels of m1 and m2 receptors (5% and 8% for SH-SY-5Y; 4% and 23% for SH-IN, respectively.) Another commonly studied cell line, 132-1-N1 astrocytoma cells, reportedly expressing M3 receptors, based upon mRNA measurements and second messenger linkage, also expresses a predominance of m3 receptors (91% of total). This m3-selective antiserum should prove useful not only for localizing and quantifying m3 muscarinic receptors but also for examining mechanisms involved in the regulation of receptor expression in human tissues or animal models of disease, as well as in cell culture.

Volume 40, Issue 5, pp. 783-789, 11/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. J. Foster, A. M. Heacock, R. F. Keep, and S. K. Fisher Activation of Muscarinic Cholinergic Receptors on Human SH-SY5Y Neuroblastoma Cells Enhances Both the Influx and Efflux of K+ under Conditions of Hypo-Osmolarity J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 457 - 465. [Abstract] [Full Text] [PDF]

				J. A. Tran, M. Matsui, and F. J. Ehlert Differential Coupling of Muscarinic M1, M2, and M3 Receptors to Phosphoinositide Hydrolysis in Urinary Bladder and Longitudinal Muscle of the Ileum of the Mouse J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 649 - 656. [Abstract] [Full Text] [PDF]

				A. M. Heacock, D. Kerley, G. T. Gurda, A. T. VanTroostenberghe, and S. K. Fisher Potentiation of the Osmosensitive Release of Taurine and D-Aspartate from SH-SY5Y Neuroblastoma Cells after Activation of M3 Muscarinic Cholinergic Receptors J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1097 - 1104. [Abstract] [Full Text] [PDF]

				R. Mitchell, D. N. Robertson, P. J. Holland, D. Collins, E. M. Lutz, and M. S. Johnson ADP-ribosylation Factor-dependent Phospholipase D Activation by the M3 Muscarinic Receptor J. Biol. Chem., September 5, 2003; 278(36): 33818 - 33830. [Abstract] [Full Text] [PDF]

				H. G. Preiksaitis, P. S. Krysiak, T. Chrones, V. Rajgopal, and L. G. Laurier Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 879 - 888. [Abstract] [Full Text]

				J. Wang, P. S. Krysiak, L. G. Laurier, S. M. Sims, and H. G. Preiksaitis Human esophageal smooth muscle cells express muscarinic receptor subtypes M1 through M5 Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1059 - G1069. [Abstract] [Full Text] [PDF]

				G. B. Willars, W. Muller-Esterl, and S. R. Nahorski Receptor phosphorylation does not mediate cross talk between muscarinic M3 and bradykinin B2 receptors Am J Physiol Cell Physiol, November 1, 1999; 277(5): C859 - C869. [Abstract] [Full Text] [PDF]

				H. Frucht, R. T. Jensen, D. Dexter, W.-L. Yang, and Y. Xiao Human Colon Cancer Cell Proliferation Mediated by the M3 Muscarinic Cholinergic Receptor Clin. Cancer Res., September 1, 1999; 5(9): 2532 - 2539. [Abstract] [Full Text] [PDF]

				G. W. Sawyer and F. J. Ehlert Muscarinic M3 Receptor Inactivation Reveals a Pertussis Toxin-Sensitive Contractile Response in the Guinea Pig Colon: Evidence for M2/M3 Receptor Interactions J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 464 - 476. [Abstract] [Full Text]

				A. S. Braverman, G. R. Luthin, and M. R. Ruggieri M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1654 - R1660. [Abstract] [Full Text] [PDF]

				M. P. Caulfield and N. J. M. Birdsall International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors Pharmacol. Rev., June 1, 1998; 50(2): 279 - 290. [Abstract] [Full Text] [PDF]

				P. G. Szekeres, J. A. Koenig, and J. M. Edwardson The Relationship between Agonist Intrinsic Activity and the Rate of Endocytosis of Muscarinic Receptors in a Human Neuroblastoma Cell Line Mol. Pharmacol., April 1, 1998; 53(4): 759 - 765. [Abstract] [Full Text]

				R. J. H. Wojcikiewicz and S. G. Luo Phosphorylation of Inositol 1,4,5-Trisphosphate Receptors by cAMP-dependent Protein Kinase. TYPE I, II, AND III RECEPTORS ARE DIFFERENTIALLY SUSCEPTIBLE TO PHOSPHORYLATION AND ARE PHOSPHORYLATED IN INTACT CELLS J. Biol. Chem., March 6, 1998; 273(10): 5670 - 5677. [Abstract] [Full Text] [PDF]

				A. S. Braverman, I. J. Kohn, G. R. Luthin, and M. R. Ruggieri Prejunctional M1 facilitory and M2 inhibitory muscarinic receptors mediate rat bladder contractility Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R517 - R523. [Abstract] [Full Text] [PDF]

				G. D'Agostino, A. Barbieri, E. Chiossa, and M. Tonini M4 Muscarinic Autoreceptor-Mediated Inhibition of [3H]Acetylcholine Release in the Rat Isolated Urinary Bladder J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 750 - 756. [Abstract] [Full Text]

				K. S. Murthy and G. M. Makhlouf Differential Coupling of Muscarinic m2 and m3 Receptors to Adenylyl Cyclases V/VI in Smooth Muscle. CONCURRENT m2-MEDIATED INHIBITION VIA Galpha i3 AND m3-MEDIATED STIMULATION VIA Gbeta gamma q J. Biol. Chem., August 22, 1997; 272(34): 21317 - 21324. [Abstract] [Full Text] [PDF]

				I. v. d. Beukel, F. A. Dijcks, P. Vanderheyden, G. Vauquelin, and M. Oortgiesen J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1113 - 1119. [Abstract] [Full Text]

				R. S. Ostrom and F. J. Ehlert M2 Muscarinic Receptor Inhibition of Agonist-induced Cyclic Adenosine Monophosphate Accumulation and Relaxation in the Guinea Pig Ileum J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 189 - 199. [Abstract] [Full Text]

				B. A. Wolf, A. M. Wertkin, Y. C. Jolly, R. P. Yasuda, B. B. Wolfe, R. J. Konrad, D. Manning, S. Ravi, J. R. Williamson, and V. M.-Y. Lee Muscarinic Regulation of Alzheimer's Disease Amyloid Precursor Protein Secretion and Amyloid beta-Protein Production in Human Neuronal NT2N Cells J. Biol. Chem., March 3, 1995; 270(9): 4916 - 4922. [Abstract] [Full Text] [PDF]

				D. A. Linseman, K. A. Heidenreich, and S. K. Fisher Stimulation of M3 Muscarinic Receptors Induces Phosphorylation of the Cdc42 Effector Activated Cdc42Hs-associated Kinase-1 via a Fyn Tyrosine Kinase Signaling Pathway J. Biol. Chem., February 16, 2001; 276(8): 5622 - 5628. [Abstract] [Full Text] [PDF]